Pirsidomine
Alternative Names: CAS 936Latest Information Update: 10 Nov 1999
At a glance
- Originator Aventis
- Class Anti-ischaemics; Small molecules; Sydnones; Vasodilators
- Mechanism of Action Nitric oxide stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Angina pectoris; Isolated systolic hypertension
Most Recent Events
- 10 Nov 1999 No-Development-Reported for Angina pectoris in Germany (PO)
- 10 Nov 1999 No-Development-Reported for Angina pectoris in USA (PO)
- 10 Nov 1999 No-Development-Reported for Isolated systolic hypertension (PO)